NASDAQ : IRON
Disc Medicine, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 82.84 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 3.68B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 79.87M | 65.38M | 33.05M | 21.86M | 14.04M | 5.76M |
| Research & Development | 188.54M | 169.79M | 96.67M | 69.26M | 33.44M | 25.17M |
| Operating Expenses | 268.41M | 235.17M | 129.72M | 91.12M | 47.48M | 30.93M |
| Operating Income | -268.41M | -235.17M | -129.72M | -91.12M | -47.48M | -30.93M |
| Interest Expense | -3.55M | -3.61M | -572.00K | |||
| Interest & Investment Income | 27.25M | 27.76M | 21.29M | 14.80M | 709.00K | 14.00K |
| Other Non Operating Income (Expenses) | -10.00K | 45.00K | -2.00K | -2.00K | -61.00K | -5.05M |
| EBT Excluding Unusual Items | -244.73M | -210.97M | -109.00M | -76.33M | -46.83M | -35.97M |
| Other Unusual Items | -852.00K | -852.00K | ||||
| Pretax Income | -245.58M | -211.82M | -109.00M | -76.33M | -46.83M | -35.97M |
| Income Tax Expense | 310.00K | 361.00K | 355.00K | 99.00K | ||
| Net Income | -245.89M | -212.18M | -109.36M | -76.43M | -46.83M | -35.97M |
| Net Income to Common | -245.89M | -212.18M | -109.36M | -76.43M | -46.83M | -35.97M |
| Shares Outstanding (Basic) | 37.50M | 35.30M | 27.61M | 22.32M | 1.04M | 878.41K |
| Shares Outstanding (Diluted) | 37.50M | 35.30M | 27.61M | 22.32M | 1.04M | 878.41K |
| EPS (Basic) | -6.56 | -6.01 | -3.96 | -3.42 | -45.05 | -40.95 |
| EPS (Diluted) | -6.56 | -6.01 | -3.96 | -3.42 | -45.05 | -40.95 |
| Free Cash Flow | -197.58M | -181.33M | -94.43M | -73.55M | -42.40M | -27.60M |
| Free Cash Flow Per Share | -5.27 | -5.14 | -3.42 | -3.30 | -40.79 | -31.42 |
| EBITDA | -268.06M | -234.89M | -129.56M | -91.03M | -47.39M | -30.90M |
| D&A For EBITDA | 355.00K | 281.00K | 156.00K | 100.00K | 89.00K | 32.00K |
| EBIT | -268.41M | -235.17M | -129.72M | -91.12M | -47.48M | -30.93M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 98.68M | 91.14M | 192.43M | 360.38M | 194.61M | 88.04M |
| Short-Term Investments | 619.07M | 700.01M | 297.45M | |||
| Cash & Short-Term Investments | 717.75M | 791.15M | 489.88M | 360.38M | 194.61M | 88.04M |
| Prepaid Expenses | 15.02M | 12.75M | 3.73M | 5.28M | 3.88M | 2.45M |
| Total Current Assets | 732.76M | 803.90M | 493.62M | 365.66M | 198.49M | 90.48M |
| Property, Plant & Equipment | 1.81M | 2.25M | 2.32M | 2.10M | 1.60M | 1.75M |
| Long-Term Deferred Charges | 400.00K | 600.00K | 600.00K | |||
| Other Long-Term Assets | 96.00K | 126.00K | 238.00K | 234.00K | 116.00K | 180.00K |
| Total Assets | 735.07M | 806.88M | 496.77M | 368.00M | 200.21M | 92.41M |
| Accounts Payable | 6.84M | 9.02M | 7.95M | 12.63M | 16.16M | 2.56M |
| Accrued Expenses | 23.20M | 27.01M | 15.24M | 8.14M | 6.11M | 4.10M |
| Current Portion of Leases | 315.00K | 611.00K | 130.00K | 665.00K | 307.00K | 319.00K |
| Other Current Liabilities | 6.45M | |||||
| Total Current Liabilities | 30.36M | 36.64M | 23.32M | 21.44M | 22.58M | 13.42M |
| Long-Term Debt | 59.34M | 29.16M | 28.32M | |||
| Long-Term Leases | 1.21M | 1.25M | 1.55M | 1.44M | 1.03M | 1.33M |
| Total Liabilities | 90.91M | 67.05M | 53.19M | 22.88M | 23.61M | 14.76M |
| Common Stock | 4.00K | 4.00K | 3.00K | 2.00K | 2.00K | |
| Additional Paid-In Capital | 1.28B | 1.25B | 741.30M | 533.76M | 288.81M | 1.19M |
| Retained Earnings | -633.22M | -510.19M | -298.00M | -188.65M | -112.22M | -65.39M |
| Comprehensive Income & Other | -1.61M | 965.00K | 289.00K | |||
| Total Common Equity | 644.16M | 739.83M | 443.59M | 345.12M | 176.60M | -64.20M |
| Shareholders' Equity | 644.16M | 739.83M | 443.59M | 345.12M | 176.60M | 77.65M |
| Total Liabilities & Equity | 735.07M | 806.88M | 496.77M | 368.00M | 200.21M | 92.41M |
| Total Debt | 60.86M | 31.02M | 30.00M | 2.10M | 1.33M | 1.65M |
| Net Cash (Debt) | 656.88M | 760.13M | 459.88M | 358.28M | 193.28M | 86.38M |
| Net Cash Per Share | 17.52 | 21.54 | 16.66 | 16.05 | 185.93 | 98.34 |
| Filing Date Shares Outstanding | 38.39M | 38.16M | 34.57M | 24.68M | 19.00M | 8.30M |
| Total Common Shares Outstanding | 38.35M | 37.89M | 29.87M | 24.36M | 17.40M | 8.30M |
| Working Capital | 702.40M | 767.26M | 470.30M | 344.22M | 175.91M | 77.06M |
| Book Value Per Share | 16.80 | 19.53 | 14.85 | 14.17 | 10.15 | -7.74 |
| Tangible Book Value | 644.16M | 739.83M | 443.59M | 345.12M | 176.60M | -64.20M |
| Tangible Book Value Per Share | 16.80 | 19.53 | 14.85 | 14.17 | 10.15 | -7.74 |
| Machinery | 415.00K | 313.00K | 162.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -245.89M | -212.18M | -109.36M | -76.43M | -46.83M | -35.97M |
| Depreciation & Amortization | 355.00K | 281.00K | 156.00K | 100.00K | 89.00K | 32.00K |
| Loss (Gain) From Sale of Investments | -4.93M | -8.52M | -5.30M | |||
| Stock-Based Compensation | 45.45M | 34.34M | 16.82M | 5.53M | 2.09M | 507.00K |
| Other Operating Activities | 1.34M | 2.16M | 533.00K | 290.00K | 272.00K | 6.61M |
| Change in Accounts Payable | 490.00K | 1.07M | -4.68M | -3.74M | 526.00K | 1.31M |
| Change in Other Net Operating Assets | 5.64M | 2.46M | 7.91M | 788.00K | 1.60M | -29.00K |
| Operating Cash Flow | -197.54M | -180.39M | -93.93M | -73.46M | -42.25M | -27.53M |
| Capital Expenditures | -46.00K | -933.00K | -505.00K | -89.00K | -151.00K | -68.00K |
| Investment in Securities | -93.37M | -393.37M | -291.83M | |||
| Investing Cash Flow | -93.42M | -394.30M | -292.33M | -89.00K | -151.00K | -68.00K |
| Long-Term Debt Issued | 28.99M | |||||
| Net Debt Issued (Repaid) | 29.98M | 28.99M | ||||
| Issuance of Common Stock | 227.63M | 459.33M | 190.72M | 201.80M | 151.12M | 68.00K |
| Other Financing Activities | 4.69M | 14.08M | -1.39M | 37.58M | -2.14M | |
| Financing Cash Flow | 262.30M | 473.41M | 218.31M | 239.38M | 148.98M | 89.93M |
| Net Cash Flow | -28.66M | -101.28M | -167.94M | 165.83M | 106.58M | 62.33M |
| Free Cash Flow | -197.58M | -181.33M | -94.43M | -73.55M | -42.40M | -27.60M |
| Free Cash Flow Per Share | -5.27 | -5.14 | -3.42 | -3.30 | -40.79 | -31.42 |
| Levered Free Cash Flow | -117.54M | -111.72M | -61.01M | -54.31M | -19.91M | -10.87M |
| Unlevered Free Cash Flow | -115.32M | -109.46M | -60.65M | -54.31M | -19.91M | -10.87M |
| Cash Interest Paid | 2.68M | 2.79M | 198.00K | |||
| Cash Income Tax Paid | 300.00K | 100.00K | ||||
| Change in Working Capital | 6.13M | 3.53M | 3.23M | -2.95M | 2.12M | 1.29M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 3.56B | 3.00B | 1.89B | 1.39B | 336.60M | |
| Enterprise Value | 2.91B | 2.41B | 1.40B | 1.03B | 424.39M | |
| Last Close Price | 80.84 | 79.41 | 63.40 | 57.76 | 19.89 | |
| PB Ratio | 4.81 | 4.05 | 4.25 | 4.04 | 1.91 | |
| P/TBV Ratio | 5.57 | 4.05 | 4.25 | 4.04 | 1.91 | |
| Debt / Equity Ratio | 0.09 | 0.04 | 0.07 | 0.01 | 0.01 | 0.02 |
| Net Debt / Equity Ratio | -1.02 | -1.03 | -1.04 | -1.04 | -1.09 | -1.11 |
| Net Debt / EBITDA Ratio | 2.45 | 3.24 | 3.55 | 3.94 | 4.08 | 2.79 |
| Net Debt / FCF Ratio | 3.33 | 4.19 | 4.87 | 4.87 | 4.56 | 3.13 |
| Quick Ratio | 23.64 | 21.59 | 21.01 | 16.81 | 8.62 | 6.56 |
| Current Ratio | 24.14 | 21.94 | 21.17 | 17.06 | 8.79 | 6.74 |
| Return on Equity (ROE) | -39.08% | -35.86% | -27.73% | -29.30% | -36.84% | -71.26% |
| Return on Assets (ROA) | -23.96% | -22.55% | -18.75% | -20.05% | -20.28% | -32.28% |
| Return on Capital Employed (ROCE) | -38.10% | -30.50% | -27.40% | -26.30% | -26.70% | -39.20% |
| Earnings Yield | -8.17% | -7.08% | -5.80% | -5.48% | -13.91% | |
| FCF Yield | -5.51% | -6.05% | -5.00% | -5.27% | -12.60% | |
| Buyback Yield / Dilution | -16.89% | -27.86% | -23.71% | -2,046.81% | -18.34% | 87.33% |